Logo
E

Excellos

31 employees

Excellos is a developer and manufacturer of cell, gene therapies.

Basic info

Industry

biotechnology research

Sectors

Alternative Medicine
Biotechnology
Advanced Materials
Life Science
cGMP Manufacturing
CDMO
Allogeneic CAR-T
Health Care
TIL Therapies
Immunotherapy Development
Product Research
Medical

Date founded

2021

Funding rounds raised

Total raised

$15M

from 1 investors over 1 rounds

E

Excellos raised $15M on January 25, 2022

Investors: Telegraph Hill Partners

FAQ